A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related Apathy

Clinical trial NCT04958031 · TERMINATED

Trial details

NCT number: NCT04958031
Sponsor: AbbVie
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Apathy in Dementia

Start date: 2021-06-22
Primary completion: 2025-02-12
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.